Surgical Management and Prognosis of Congenital Choledochal Cysts in Adults: A Single Asian Center Cohort of 69 Cases

Table 5

Demographic and clinical data of patients with concomitant malignancy or developed postoperative malignancy.

AD/sex	DC (m)	Follow-up (m)	AM	Cyst type	Symptoms	APBJ and complications	First surgery	CE	Length of the Y limb (cm)	Diameter of the CIA	Surgical approach	Other operations	HS	BL	PC	Pathology	SR	Outcome
36/F	96	47	44	IV	Abdominal pain, nausea/vomit	APBJ, malignancy, cholecystitis	CCE and RYHJ	—	—	—	1	no	20	—	Cholangitis	Moderately differentiated CCA, T2N0M0	Yes	Alive
23/F	2	37	23	IV	Abdominal pain, jaundice, nausea/vomit	APBJ, malignancy, cholecystolithiasis, choledocholithiasis, cholecystitis, cholangitis	RRC and PH	Yes	50	2.0	1	MRCP	19	300	Cholangitis	Well-differentiated CCA, T2N0M0	No	Alive
65/F	1	65	65	I	Incidental finding	APBJ, malignancy, cholecystitis	CCE, RYHJ, and RRC	Yes	50	1.2	3	no	18	400	no	Well-differentiated CCA, T1N0M0	No	Alive
63/F	8	32	63	I	Charcot’s triad, nausea/vomit	Malignancy, cholecystolithiasis, cholecystitis, pancreatitis	CCE and RYHJ	Yes	50	—	2	No	15	80	Cholangitis	Well-differentiated GAC, T2N0M0	No	Alive
39/F	84	100	46	IV	Abdominal pain	Malignancy, cholecystolithiasis, cholecystitis	CCE, RYHJ, and RRC	No	50	2.0	1	MRCP	13	150	—	GAC, T3N0M0	-	Alive
52/F	1	124	53	IV	Charcot’s triad, nausea/vomit	APBJ, cholecystolithiasis, choledocholithiasis, cholecystitis, cholangitis	CCE and RYHJ	No	50	3.0	1	ERCP, MRCP	23	300	Malignancy	T4N2M1	Yes	Deceased
3/M	480	440	43	I	Charcot’s triad	APBJ, choledocholithiasis, cholecystitis, cholangitis	Choledochocyst duodenostomy	-	45	—	1	—	73	-	Malignancy, choledocholithiasis, cholangitis	Moderately poorly differentiated CCA, T3N1M0	Yes	Deceased

AD: age at diagnosis (years), F: female, M: male, DC: disease course (months), AM: age when malignancy discovered (years), CE: complete excision, surgical approaches include 1, open; 2, laparoscopic; and 3, laparoscopic converted to open, HS: hospital stay (days), BL: blood loss (mL), PC: postoperative complication, SR: surgical re-excision, CCE: cholecystectomy and choledochal cysts excision, CIA: cholangio-intestinal anastomosis, ERCP: endoscopic retrograde cholangiopancreatography, MRCP: magnetic resonance cholangiopancreatography, CCA: cholangiocarcinoma, GAC: gallbladder adenocarcinoma, PH: partial hepatectomy, RRC: radical resection of cholangiocarcinoma, and RYHJ: Roux-en-Y hepaticojejunostomy.